HuSIGHT and EnviroSIGHT — InSIGHTs for Parkinson’s Disease

Parkinson’s disease research increasingly points toward immune mechanisms — autoreactive antibodies, environmental triggers, and microbial co-exposures that shape onset and progression. This brochure shows how Infinity Bio’s HuSIGHT™ and EnviroSIGHT™ antibody reactome libraries map both arms of that immune signal in one cost-effective MIPSA-based assay so Parkinson’s investigators can profile autoantibody reactivity against the entire human proteome alongside antibody responses to non-viral pathogens, microbiome members, parasites, and environmental allergens. The combined readout is designed to surface novel autoantigens, characterize antibody binding profiles for therapeutic development, and reveal exposure patterns relevant to pathogenesis, progression, and patient stratification.

Read or download to see:

• What HuSIGHT™ measures: an unbiased search for autoantibodies against any human protein, using both peptides and proteins for broader autoantigen identification in Parkinson’s patients.
• What EnviroSIGHT™ adds: antibody responses to non-viral pathogens, microbiome members, parasites, and food, plant, fungal, and insect-vector allergens that virus-only panels miss.
• How the two libraries combine into a single cost-effective MIPSA assay that captures autoimmune signal and environmental exposure history in one readout per sample.
• How comprehensive immune reactome mapping at cohort scale is now feasible — and what it unlocks for diagnostics, therapeutics, biomarker discovery, and patient stratification in Parkinson’s research.